Oculogica, the leader in non-invasive assessment of concussion, announces today the granting of U.S. Patent No. 10,863,902 by the U.S. Patent and Trademark Office. This patent protects Oculogica’s method and system for assessing glaucoma in a patient using a noninvasive eye tracking system.
Oculogica’s Drs. Rosina and Uzma Samadani Named in Fast Company’s Annual List of the Most Creative People in Business
Oculogica Founder, Dr. Uzma Samadani and CEO, Dr. Rosina Samadani, join the 11th annual list of women and men from such companies as Netflix, Google, and Patagonia, as well as institutions such as Johns Hopkins University and the ACLU of Massachusetts.
Last year, the FDA granted authorization for commercial use of the first tool that provides an objective diagnosis of concussions. Called EyeBox, it was developed by sisters Uzma and Rosina Samadani.
EyeBOX Featured in Weekly Interview with The Daily Show’s Trevor Noah & Microsoft President Brad Smith
Watch our EyeBOX technology featured in Trevor Noah’s and Microsoft President Brad Smith’s discussion with Green Bay Packers President & CEO Mark Murphy.
Midwest Orthopaedics at Rush (MOR) is the first in Illinois to offer a new eye-tracking technology to more quickly identify a patient with ocular changes after a potential concussion or traumatic brain injury.
TitletownTech today announced it has invested in Oculogica, an innovative digital health company, by leading an $8 million round of funding that recently closed.
Their device promises faster and more accurate concussion assessments. A venture fund started by the Green Bay Packers took notice.
A venture fund led by the Green Bay Packers and Microsoft has invested in a new technology that promises to provide a major advance in the diagnosis of concussions.
Oculogica, Inc., a pioneer in algorithm-based neuro-diagnostics for brain health, announced today that the American Medical Association (AMA) has confirmed the addition of a new Category 3 CPT Code, 0X17T, Eye movement analysis test without spatial calibration, allowing clinicians to appropriately report the services related exclusively to the Oculogica EyeBOX® exam.
FDA: The FDA Recommends Only Using Cleared or Approved Medical Devices to Help Assess or Diagnose a Head Injury, Including Concussion: FDA Safety Communication
Certain products intended to aid in the assessment, diagnosis, or management of a head injury, which includes concussion, traumatic brain injury (TBI), and mild traumatic brain injury (mild TBI or mTBI) are considered medical devices regulated by the FDA.
Recent Blog Posts
New posts coming soon